The aim of the current project is to validate PDE4 inhibitors as a target for cognition
enhancers (proof-of-concept) using a translational behaviour-EEG approach. The project will
demonstrate whether memory, but also attention, information processing or executive function
improves with the PDE4 inhibitor roflumilast in healthy humans.
Phase:
Phase 2
Details
Lead Sponsor:
Maastricht University Medical Center
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development